Small-cell lung cancer in never-smokers: a case series with information on family history of cancer and environmental tobacco smoke. Clin Lung Cancer, 2012, 13: 75-79.Kurahara Y, Kawaguchi T, Tachibana K et al. Small-cell lung cancer in never- smokers: a case series with information on...
【Cancer Cell】Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes 小细胞肺癌(SCLC)是有多重亚型的恶性肿瘤,但目前临床对亚型进行区分却有很大挑战。此项新临床研究,由美国MD Anderson癌症中心科学家团队领衔,发表在Cell子刊Cancer Cell(影响因子 50.3),建立了...
Scientific Information Request on Imaging for Pretreatment Staging of Small Cell Lung CancerRichard Kronick
What You Need To Know About Cancer of the Cervix Prostate Problems Prostate Cancer Parkinson's Disease - Hope Through Research Multiple Sclerosis: Hope Through Research Questions and Answers on the Use of Hormones After Menopause for Osteoporosis About Lung Cancer What You Need To Know About Liver...
To maintain a refined and specific focus on the information needs and sources of cancer patients, the following were excluded: (1) articles focusing on information needs and/or information sources for family members of cancer patients, (2) articles focusing on cancer-related information needs or ...
YTHDF2, a prominent player in the regulation of post-transcriptional events, has emerged as a key modulator of YAP mRNA degradation in the context of non-small cell lung cancer (NSCLC) [122,123]. This regulatory process is intricately governed by the m6A modification and interaction with the...
Non-Small Cell Lung Cancer Treatment (PDQ®): Treatment-Health Professional Information [NCI]Note: Some citations in the text of this section are followed by a level of evidence. The PDQ editorial boards use a formal ranking system to help the reade...
In patients with non-small cell lung carcinoma (NSCLC) fluorine-18 fluorodeoxyglucose positron emission tomography (18FDG-PET)-scanning is shown to be of prognostic value. Small cell lung cancer (SCLC) is an aggressive tumor with poor prognosis. Limited results on the prognostic and predictive val...
1.2 Non-small Cell Lung Cancer TAXOTERE as a single agent is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of prior platinum-based chemotherapy. TAXOTERE in combination with cisplatin is indicated for the treatment of patients wi...
The usual dose of Etoposide Injection USP in testicular cancer in combination with other approved chemotherapeutic agents ranges from 50 to 100 mg/m 2/day on days 1 through 5 to 100 mg/m 2/day on days 1, 3, and 5. In small cell lung cancer, the Etoposide Injection USP dose in comb...